Haas Thorsten, Cushing Melissa M
Department of Pediatric Anesthesia, Zurich University Children's Hospital, Zurich, Switzerland.
Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, United States.
Front Pediatr. 2020 Nov 11;8:600501. doi: 10.3389/fped.2020.600501. eCollection 2020.
Acute coagulopathy is prevalent in adult and pediatric trauma patients and is associated with increased morbidity and mortality. While reasonable hypotheses have been created to explain the underlying perturbations of adult trauma coagulopathy (i.e., tissue factor-related increase in thrombin generation, protein C activation, hypoperfusion, and hyperfibrinolysis), only a small number of studies have been performed to prove whether these mechanisms can likewise be detected in pediatric trauma patients. In addition, severe hypofibrinogenemia (<100 mg/dL) is a frequent finding in pediatric trauma patients (>20%). Although the probability of life-threatening coagulopathy is low with minor to moderate injury, it is present in almost all patients with an injury severity score >25, hypotension, hypothermia, and acidosis. As these multifactorial changes in hemostasis cannot be adequately and rapidly measured using standard laboratory testing, the use of viscoelastic measurements has been established in adult trauma management, but prospective studies in children are urgently needed. Apart from diagnostic challenges, several studies have focused on the impact of blood product ratios on the treatment of massively bleeding pediatric trauma patients. The majority of these studies were unable to show improved survival by using higher plasma to red blood cell ratios or higher platelet to red blood cells ratios, but there are no published randomized trials to definitively answer this question. A goal-directed transfusion protocol using viscoelastic tests together with early substitution with an antifibrinolytic and fibrinogen replacement is a promising alternative to traditional ratio-based interventions. Another crucial factor in treating trauma-induced coagulopathy is the early detection of hypofibrinogenemia, a common condition in massively transfused patients. Early treatment of hypofibrinogenemia is associated with improved morbidity and mortality in adults, but needs to be further studied in future pediatric trials. Pediatric trauma patients are not only threatened by coagulopathy-related bleeding but are also at higher risk for venous thromboembolism. Pediatric trauma patients with brain injury, central venous catheters, immobilization, or surgical procedures are at highest risk for developing a deep venous thrombosis. There are no specific pediatric guidelines established to prevent venous thromboembolism in children suffering from traumatic injury.
急性凝血病在成年和儿科创伤患者中普遍存在,与发病率和死亡率增加相关。虽然已经提出了合理的假设来解释成人创伤凝血病的潜在紊乱(即组织因子相关的凝血酶生成增加、蛋白C激活、低灌注和高纤维蛋白溶解),但只有少数研究来证明这些机制是否同样能在儿科创伤患者中检测到。此外,严重低纤维蛋白原血症(<100mg/dL)在儿科创伤患者中很常见(>20%)。虽然轻度至中度损伤导致危及生命的凝血病的可能性较低,但几乎所有损伤严重程度评分>25、低血压、体温过低和酸中毒的患者都存在这种情况。由于使用标准实验室检测无法充分快速地测量这些止血方面的多因素变化,成人创伤管理中已开始使用粘弹性测量,但迫切需要针对儿童的前瞻性研究。除了诊断方面的挑战,一些研究关注了血液制品比例对大量出血的儿科创伤患者治疗的影响。这些研究大多未能表明使用更高的血浆与红细胞比例或更高的血小板与红细胞比例能提高生存率,但尚无已发表的随机试验来明确回答这个问题。使用粘弹性试验以及早期用抗纤维蛋白溶解剂替代和补充纤维蛋白原的目标导向输血方案是传统基于比例的干预措施的一个有前景的替代方案。治疗创伤性凝血病的另一个关键因素是早期发现低纤维蛋白原血症,这在大量输血患者中很常见。低纤维蛋白原血症的早期治疗与成人发病率和死亡率的改善相关,但需要在未来的儿科试验中进一步研究。儿科创伤患者不仅受到凝血病相关出血的威胁,而且发生静脉血栓栓塞的风险也更高。患有脑损伤、中心静脉导管、制动或接受手术的儿科创伤患者发生深静脉血栓形成的风险最高。目前尚无专门针对预防创伤性损伤儿童静脉血栓栓塞的儿科指南。